Cullinan Oncology LLC Total Liabilities

Latest as of March 2026: $36.81 Million USD

Cullinan Oncology LLC total liabilities. Based on the latest financial reports, Cullinan Oncology LLC (CGEM) has total liabilities worth $36.81 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Cullinan Oncology LLC liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Cullinan Oncology LLC (2012–2025)

Total liabilities of Cullinan Oncology LLC from 2012 to 2025. This chart illustrates how Cullinan Oncology LLC's total liabilities have evolved over time, based on quarterly financial data. Explore CGEM long-term investment intensity to see how much of total assets are deployed in long-term investments.

Cullinan Oncology LLC Competitors by Total Liabilities

The table below lists competitors of Cullinan Oncology LLC ranked by their total liabilities.

Company	Country	Total Liabilities
Dynamatic Technologies Limited NSE:DYNAMATECH	India	Rs9.94 Billion
Boai NKY Pharmaceuticals Ltd SHE:300109	China	CN¥961.75 Million
TOA Paint (Thailand) Public Company Limited BK:TOA	Thailand	฿6.22 Billion
Major Drilling Group International TO:MDI	Canada	CA$231.07 Million
Quechen Silicon Chemical Co. Ltd. SHG:605183	China	CN¥578.50 Million
Sprinklr Inc NYSE:CXM	USA	$573.39 Million
Jiajiayue Group Co Ltd SHG:603708	China	CN¥9.56 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Cullinan Oncology LLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Cullinan Oncology LLC (CGEM) total assets.

Liquidity & Leverage Metrics

Cullinan Oncology LLC Total Liabilities Ratios Explained

Cullinan Oncology LLC total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	10.28	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.10	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.09	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cullinan Oncology LLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cullinan Oncology LLC (2012–2025)

The table below shows the annual total liabilities of Cullinan Oncology LLC from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	$39.64 Million	+25.87%
2024-12-31	$31.50 Million	+3.99%
2023-12-31	$30.29 Million	+16.10%
2022-12-31	$26.09 Million	+120.88%
2021-12-31	$11.81 Million	-17.94%
2020-12-31	$14.39 Million	-89.75%
2019-12-31	$140.37 Million	+153.88%
2018-12-31	$55.29 Million	+9461.03%
2016-12-31	$578.28K	-53.55%
2015-12-31	$1.24 Million	+8.10%
2014-12-31	$1.15 Million	+12.08%
2013-12-31	$1.03 Million	+218.11%
2012-12-31	$323.00K	--

About Cullinan Oncology LLC

NASDAQ:CGEM USA Biotechnology

Market Cap

$967.96 Million

Market Cap Rank

#9023 Global

#2572 in USA

Share Price

$15.75

Change (1 day)

+5.49%

52-Week Range

$7.19 - $22.95

All Time High

$53.42